Nine Chapters Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Nine Chapters Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-56,900	Closed	-$1.13M	–	757
2015 Q3	$1.13M	Buy	56,900 +47,000	+475%	+$1.48M	0.1%	305
2015 Q2	$344K	Sell	9,900 -37,600	-79%	-$1.15M	0.03%	686
2015 Q1	$1.23M	Buy	47,500 +29,100	+158%	+$533K	0.1%	302
2014 Q4	$237K	Buy	+18,400	New	+$230K	0.02%	744
2013 Q3	–	Sell	-13,700	Closed	-$34K	–	967
2013 Q2	$34K	Buy	+13,700	New	+$32.9K	0.01%	607

Other funds holding HZNP

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Nine Chapters Capital Management's HZNP Position: Q4 2015 in Review

Nine Chapters Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2015, closing a stake of 56,900 shares — an estimated $1.13M sold.

Nine Chapters Capital Management first reported a position in HZNP in Q2 2013 and held it in 5 quarters. The position peaked at $1.23M in Q1 2015. 202 funds tracked by Wall St. Rank hold HZNP as of Q4 2015.

Nine Chapters Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2015 after selling out during the quarter.
Nine Chapters Capital Management sold 56,900 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2015, an estimated $1.13M.
Nine Chapters Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 5 quarters.
Nine Chapters Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.23M in Q1 2015.
202 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2015.

Based on Nine Chapters Capital Management's 13F filing for Q4 2015.